FDA approves new type of heart failure drug from Amgen

Patients with chronic heart failure, a deadly disease that worsens as the heart pumps less blood through the body, are getting a much-needed new option.

The Food and Drug Administration has approved a novel drug from Amgen for reducing hospitalizations in some .

Corlanor (coor'LAHN'-or) is the first medication in a dozen years for the increasingly common condition. Chronic heart kills up to half of patients within five years, despite numerous existing treatments.

Rival drugmaker Novartis has another heart failure pill under review by the FDA. It could be approved this summer.

Roughly 6 million Americans and 26 million people worldwide have , mostly as a chronic condition.

It's becoming more common along with obesity and because more people survive heart attacks due to better treatments.

Explore further

Remote monitoring device approved for heart patients

© 2015 The Associated Press. All rights reserved.

Citation: FDA approves new type of heart failure drug from Amgen (2015, April 15) retrieved 22 January 2021 from https://medicalxpress.com/news/2015-04-fda-heart-failure-drug-amgen.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments